loadpatents
name:-0.033605098724365
name:-0.015996932983398
name:-0.0091321468353271
Institut Regional du Cancer de Montpellier Patent Filings

Institut Regional du Cancer de Montpellier

Patent Applications and Registrations

Patent applications and USPTO patent grants for Institut Regional du Cancer de Montpellier.The latest application filed is for "method for screening a subject for a cancer".

Company Profile
7.22.33
  • Institut Regional du Cancer de Montpellier - MONTPELLIER FR
  • INSTITUT REGIONAL DU CANCER DE MONTPELLIER -
  • INSTITUT REGIONAL DU CANCER DE MONTPELLIER - MONTEPELLIER CEDX 5 FR
  • INSTITUT REGIONAL DU CANCER DE MONTPELLIER - Montpellier Cedex 5 FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Method For Screening A Subject For A Cancer
App 20220290244 - THIERRY; Alain
2022-09-15
Use Of Mullerian Inhibiting Substance Inhibitors For Treating Cancer
App 20220290151 - PELEGRIN; Andre ;   et al.
2022-09-15
In Vitro Method For Assessing The Risk Of Prostate Side Effect After Treatment By Ionizing Radiation
App 20220157462 - FRANC; Clemence ;   et al.
2022-05-19
In Vitro Method For Assessing The Risk Of Prostate Side Effect After Treatment By Ionizing Radiation
App 20220137030 - Azria; David ;   et al.
2022-05-05
Methods For Determining The Quality Of An Embryo
App 20220106643 - HAMAMAH; Samir ;   et al.
2022-04-07
Methods And Kits For Detecting Egfr Mutations
App 20220073993 - THIERRY; ALAIN ;   et al.
2022-03-10
Methods And Compositions For Treating Cancers By Immuno-modulation Using Antibodies Against Cathespin-d
App 20220064332 - LIAUDET-COOPMAN; Emmanuelle ;   et al.
2022-03-03
Monoclonal antibodies binding to the CD160 transmembrane isoform
Grant 11,186,635 - Bensussan , et al. November 30, 2
2021-11-30
Methods for determining the quality of an embryo
Grant 11,149,314 - Hamamah , et al. October 19, 2
2021-10-19
Combination For Treating Cancer
App 20210290633 - MARAVER; Antonio ;   et al.
2021-09-23
Polypeptides For Preparing Drug Conjugates Capable Of Promoting Apoptosis In A Cell Expressing An Orexin Receptor
App 20210188983 - ROBERT; Bruno ;   et al.
2021-06-24
Method For Screening A Subject For Cancer
App 20210172019 - THIERRY; Alain ;   et al.
2021-06-10
Anti-human-HER3 antibodies and uses thereof
Grant 11,001,634 - Chardes , et al. May 11, 2
2021-05-11
Methods For Screening A Subject For A Cancer
App 20200399707 - THIERRY; Alain ;   et al.
2020-12-24
Method And Pharmaceutical Compositions For The Treatment Of Multiple Myeloma
App 20200330467 - MOREAUX; Jerome ;   et al.
2020-10-22
Human monoclonal antibodies against orexin receptor type 1
Grant 10,758,615 - Couvineau , et al. Sep
2020-09-01
Methods for screening a subject for a cancer
Grant 10,704,104 - Thierry , et al.
2020-07-07
Human monoclonal antibodies fragments inhibiting both the Cath-D catalytic activity and its binding to the LRP1 receptor
Grant 10,526,415 - Liaudet-Coopman , et al. J
2020-01-07
Human monoclonal antibodies against AXL
Grant 10,398,774 - Robert , et al. Sep
2019-09-03
Monoclonal Antibodies Binding To The Cd160 Transmembrane Isoform
App 20190256595 - BENSUSSAN; Armand ;   et al.
2019-08-22
Neuregulin allosteric anti-HER3 antibody
Grant 10,196,455 - Chardes , et al. Fe
2019-02-05
Methods For Determining The Quality Of An Embryo
App 20190002985 - HAMAMAH; Samir ;   et al.
2019-01-03
Method For Evaluating Individual Radiosensitivity And The Risk Of Adverse Effects
App 20180363057 - SCHMITZ; ANNETTE ;   et al.
2018-12-20
Anti-nrg1 (heregulin) Antibodies And Uses Thereof
App 20180291098 - Ogier; Charline ;   et al.
2018-10-11
Method for determining radiosensitivity
Grant 10,001,491 - Azria , et al. June 19, 2
2018-06-19
Anti-human-her3 Antibodies And Uses Thereof
App 20180155433 - CHARD S; Thierry ;   et al.
2018-06-07
Human Monoclonal Antibodies Fragments Inhibiting Both The Cath-d Catalytic Activity And Its Binding To The Lrp1 Receptor
App 20180127510 - LIAUDET-COOPMAN; Emmanuelle ;   et al.
2018-05-10
Human neutralizing anti-kit antibodies and uses thereof
Grant 9,932,410 - Poul , et al. April 3, 2
2018-04-03
Anti-claudin 1 antibodies for use in the treatment of colorectal cancer
Grant 9,931,416 - Del Rio , et al. April 3, 2
2018-04-03
Orexin-b Polypeptides And Uses Thereof
App 20180044393 - COUVINEAU; Alain ;   et al.
2018-02-15
Human Monoclonal Antibodies Against Orexin Receptor Type 1
App 20180030135 - COUVINEAU; Alain ;   et al.
2018-02-01
Human Monoclonal Antibodies Against Orexin Receptor Type 1
App 20180002421 - COUVINEAU; Alain ;   et al.
2018-01-04
Human Monoclonal Antibodies Against Axl
App 20170340734 - ROBERT; Bruno ;   et al.
2017-11-30
Methods For Screening A Subject For A Cancer
App 20170240975 - THIERRY; Alain ;   et al.
2017-08-24
Methods For Predicting The Survival Time Of Patients Suffering From Cancer
App 20170183742 - THIERRY; Alain ;   et al.
2017-06-29
Association of poly(N-acryloylglycinamide) with at least one active principle
Grant 9,687,552 - Boustta , et al. June 27, 2
2017-06-27
Neuregulin Allosteric Anti-HER3 Antibody
App 20160319033 - Chardes; Thierry ;   et al.
2016-11-03
Human Neutralizing Anti-Kit Antibodies and Uses Thereof
App 20160264680 - Poul; Marie-Alix ;   et al.
2016-09-15
Anti-Claudin 1 Antibodies and Uses Thereof
App 20160185856 - DEL RIO; Marguerite ;   et al.
2016-06-30
Anti-Claudin 1 Antibodies for Use in the Treatment of Colorectal Cancer
App 20160158380 - Del Rio; Marguerite ;   et al.
2016-06-09
Methods For Determining The Quality Of An Embryo
App 20160138104 - HAMAMAH; Samir ;   et al.
2016-05-19
Method for Determining Radiosensitivity
App 20160054337 - Azria; David ;   et al.
2016-02-25
Intracellular Phenotypic Screening
App 20150346192 - DARIAVACH; Piona ;   et al.
2015-12-03
Association Of Poly(n-acryloylglycinamide) With At Least One Active Principle
App 20150122695 - Boustta; Mahfoud ;   et al.
2015-05-07
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed